hs-Troponin Delta Algorithm (0 to1-h and 0 to 2-h ESC models) Calculator
Patient measurements
Enter serial high-sensitivity troponin T results in ng/L. Samples must be collected at the specified time points.
ESC 2023Roche Elecsys hs-cTnT
Enter a baseline value and at least one valid follow-up value to calculate the corresponding ESC pathway. A baseline-only result can be assessed for direct rule-out only when symptom onset was more than 3 hours earlier.
How to interpret the pathways
This calculator implements the published ESC rapid algorithm cutoffs for Roche Elecsys high-sensitivity cardiac troponin T (hs-cTnT). Do not use these thresholds for a different troponin assay or platform.
Assay-specific thresholds
| Pathway | Rule-out | Rule-in |
|---|---|---|
| 0/1 hour | 0 h <5 ng/L if symptom onset >3 h; or 0 h <12 ng/L and absolute 1 h delta <3 ng/L | 0 h ≥52 ng/L or absolute 1 h delta ≥5 ng/L |
| 0/2 hour | 0 h <5 ng/L if symptom onset >3 h; or 0 h <14 ng/L and absolute 2 h delta <4 ng/L | 0 h ≥52 ng/L or absolute 2 h delta ≥10 ng/L |
Clinical application
- Rule-out: the algorithmic rule-out pathway is not, by itself, a decision to discharge. Integrate symptoms, ECG, examination, and the overall clinical risk.
- Rule-in: indicates a high probability pathway requiring prompt clinical assessment; troponin elevation can occur in conditions other than type 1 MI.
- Observe: further assessment is required. ESC guidance describes repeat hs-cTn at around 3 hours, with echocardiography as appropriate.
- Ongoing or recurrent chest pain, ischemic ECG changes, hemodynamic instability, or strong clinical suspicion require urgent evaluation regardless of calculator output.
References
Byrne RA, Rossello X, Coughlan JJ, et al.
2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720–3826. doi:10.1093/eurheartj/ehad191.
Official guideline DOI
Collet JP, Thiele H, Barbato E, et al.
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575.
Guideline DOI
Clinical disclaimer: For healthcare professional use as a decision-support aid. This implementation uses Roche Elecsys hs-cTnT cutoffs and should only be used where the local assay and laboratory reporting are compatible. It does not diagnose or exclude myocardial infarction independently of clinical assessment and ECG. Follow local protocols and current laboratory guidance.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.